05 August 2010

New Drug Studied for Hard-to-Treat Vascular Condition

Clinical trials suggest icatibant safe, effective against life-threatening swelling of hereditary angioedema

This article has not necessarily been edited by Health24.

The condition is caused by low levels or poor function of a protein called C1 esterase inhibitor. The new drug, icatibant, blocks the receptor for a protein called bradykinin, which is thought to play a role in many HAE symptoms.


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.